Experience with XXXX and @entity8473 as an oral contraceptive.

@entity1 @entity11321 @entity8473 @entity1031
A study was made in Bombay, India of oral contraception using 2 combinations of @entity11321 and @entity8473 in 521 @entity1 over a period of 3 years with a total of 5196 menstrual cycles. The @entity1 were divided into 2 groups: 1 using 1 mg of @entity11321 plus .1 mg of @entity8473 and the other using .5 mg of @entity11321 and .1 mg of @entity8473 . 70% of the @entity1 studied were aged 21-30 years. @entity1 over 35 and those with more than 3 @entity1 were urged to undergo operative procedures. Most had used no contraceptive method previously, 56.6% desired planned families, and 43.4% wanted no more @entity1 . There was a monthly interview when a new supply of tablets was distributed. No pregnancies followed in either group when tablets were taken regularly, but 2 did occur otherwise. Side effects were most severe during the first cycle. 55 @entity1 (10.5%) discontinued medication at the end of 3 years because of side effects. 267 discontinued the program because pills were not available near their homes. Of these, 71 became pregnant over the 3-year period, only 10 of whom desired pregnancy. None showed evidence of @entity1031 phenomena. Liver function tests showed no change. The cycle length of most @entity1 taking the preparations became more regular at 27-28 days. There was little difference in side effects of the 2 preparations.
